Squarepoint Ops LLC Myriad Genetics Inc Transaction History

Squarepoint Ops LLC

  • $62.8 Billion
  • Q3 2024

A detailed history of Squarepoint Ops LLC transactions in Myriad Genetics Inc stock. As of the latest transaction made, Squarepoint Ops LLC holds 109,345 shares of MYGN stock, worth $1.67 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
109,345
Previous 27,286 300.74%
Holding current value
$1.67 Million
Previous $667,000 348.58%
% of portfolio
0.0%
Previous 0.0%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
BUY
$23.97 - $28.6 $1.97 Million - $2.35 Million
82,059 Added 300.74%
109,345 $2.99 Million
Q2 2024

Aug 14, 2024
SELL
$17.98 - $25.47 $1.07 Million - $1.51 Million
-59,290 Reduced 68.48%
27,286 $667,000
Q1 2024

May 15, 2024
BUY
$17.59 - $23.59 $801,611 - $1.08 Million
45,572 Added 111.14%
86,576 $1.85 Million
Q4 2023

Feb 14, 2024
BUY
$13.91 - $21.32 $359,754 - $551,399
25,863 Added 170.81%
41,004 $784,000
Q2 2023

Aug 14, 2023
SELL
$17.56 - $23.76 $202,256 - $273,667
-11,518 Reduced 43.2%
15,141 $350,000
Q1 2023

May 15, 2023
SELL
$15.26 - $23.75 $2.13 Million - $3.32 Million
-139,725 Reduced 83.98%
26,659 $619,000
Q4 2022

Feb 14, 2023
BUY
$14.51 - $20.99 $2.04 Million - $2.95 Million
140,496 Added 542.71%
166,384 $2.41 Million
Q3 2022

Nov 14, 2022
BUY
$18.21 - $27.88 $471,420 - $721,757
25,888 New
25,888 $494,000
Q4 2020

Feb 16, 2021
SELL
$12.16 - $19.77 $436,081 - $708,991
-35,862 Closed
0 $0
Q3 2020

Nov 16, 2020
SELL
$11.25 - $14.75 $575,898 - $755,067
-51,191 Reduced 58.8%
35,862 $468,000
Q2 2020

Aug 14, 2020
BUY
$10.69 - $16.49 $930,596 - $1.44 Million
87,053 New
87,053 $987,000
Q4 2019

Feb 14, 2020
SELL
$20.93 - $35.1 $161,161 - $270,270
-7,700 Closed
0 $0
Q3 2019

Nov 14, 2019
SELL
$22.08 - $47.08 $1.46 Million - $3.1 Million
-65,938 Reduced 89.54%
7,700 $220,000
Q2 2019

Aug 14, 2019
BUY
$22.67 - $35.0 $1.67 Million - $2.58 Million
73,638 New
73,638 $2.05 Million
Q1 2019

May 15, 2019
SELL
$26.93 - $34.7 $517,998 - $667,454
-19,235 Closed
0 $0
Q4 2018

Feb 14, 2019
BUY
$27.23 - $45.56 $70,689 - $118,273
2,596 Added 15.6%
19,235 $559,000
Q3 2018

Nov 14, 2018
BUY
$37.57 - $50.34 $625,127 - $837,607
16,639 New
16,639 $765,000
Q2 2018

Aug 14, 2018
SELL
$27.75 - $40.17 $1.18 Million - $1.71 Million
-42,560 Closed
0 $0
Q1 2018

May 15, 2018
BUY
$28.83 - $41.01 $505,793 - $719,479
17,544 Added 70.13%
42,560 $1.26 Million
Q4 2017

Feb 14, 2018
SELL
$28.45 - $37.14 $777,140 - $1.01 Million
-27,316 Reduced 52.2%
25,016 $859,000
Q3 2017

Nov 14, 2017
BUY
$24.01 - $36.2 $1.26 Million - $1.89 Million
52,332
52,332 $1.89 Million

Others Institutions Holding MYGN

# of Institutions
253
Shares Held
90.9M
Call Options Held
100K
Put Options Held
34K
View Full List

About MYRIAD GENETICS INC

MYGN Quotes by TradingView
  • Ticker MYGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 80,634,800
  • Market Cap $1.23B
  • Description
  • Myriad Genetics, Inc., a genetic testing and precision medicine company, develops and commercializes genetic tests in the United States and internationally. The company offers molecular diagnostic tests for use in oncology, and women's and mental health applications. It provides MyRisk Hereditary Cancer Test, a DNA sequencing test for assessing ...
More about MYGN
Track This Portfolio

Track Squarepoint Ops LLC Portfolio

Follow Squarepoint Ops LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Squarepoint Ops LLC, based on Form 13F filings with the SEC.

News

Stay updated on Squarepoint Ops LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email